Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension

NCT00503360 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis